Impaired functioning in euthymic patients with bipolar disorder - HSV-1 as a predictor

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 110-116

  Gerber, Sonja I ^a   Krienke, Ute J ^b   Biedermann, Nane Christine ^a   Grunze, Heinz ^c   Yolken, Robert H ^d   Dittmann, Sandra ^e   Langosch, Jens M ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Bethanien Hospital for Psychiatry Psychosomatics and Psychotherapy   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Bipolar disorder; Cognitive impairment; HSV 1; Quality of life; RBANS

Indexed keywords

ADULT; AGED; ANTIBODY TITER; ARTICLE; ATTENTION DISTURBANCE; BIPOLAR DISORDER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FUNCTIONAL DISEASE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; LANGUAGE DISABILITY; MALE; MEDICAL HISTORY; MENTAL DISEASE; NEUROLOGIC EXAMINATION; PREDICTOR VARIABLE; QUALITY OF LIFE; SELF EVALUATION; SHORT TERM MEMORY; SOCIAL STATUS;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; FEMALE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; THYMUS GLAND; YOUNG ADULT;

EID: 82555165974     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.09.003     Document Type: Article

References (49)

1. Balanza-Martinez V., Tabares-Seisdedos R., Selva-Vera G., Martinez-Aran A., Torrent C., Salazar-Fraile J., et al. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom 2005, 74:113-119.
2. Bowie C.R., Harvey P.D. Administration and interpretation of the Trail Making Test. Nat Protoc 2006, 1:2277-2281.
3. Clark L., Iversen S.D., Goodwin G.M. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002, 180:313-319.
4. Cotter D.R., Pariante C.M., Everall I.P. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001, 55:585-595.
5. Dean B.B., Gerner D., Gerner R.H. A systematic review evaluating health-related quality of life, work impairment, and healthcare costs and utilization in bipolar disorder. Curr Med Res Opin 2004, 20:139-154.
6. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Ruslanova I., Yolken R.H. Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Arch Gen Psychiatry 2003, 60:466-472.
7. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Cole S., Krivogorsky B., et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry 2004, 55:588-593.
8. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Cole S., Leister F., et al. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder. Bipolar Disord 2006, 8:124-132.
9. Dittmann S., Hennig-Fast K., Gerber S., Seemuller F., Riedel M., Emanuel Severus W., et al. Cognitive functioning in euthymic bipolar I and bipolar II patients. Bipolar Disord 2008, 10:877-887.
10. Drieling T., Scherer-Klabunde D., Schaerer L.O., Biedermann N.C., Post R.M., Langosch J.M. Interpersonal and instrumental functioning of patients with bipolar disorder depends on remaining depressive symptoms. German J Psychiatry 2010, 13:61-65.
11. Ferrier I.N., Stanton B.R., Kelly T.P., Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999, 175:246-251.
12. Figueira M.L., Ouakinin S. From psychosomatic to psychological medicine: what's the future?. Curr Opin Psychiatry 2008, 21:412-416.
13. First M.B., Gibon M., Spitzer R.L. Structured Clinical Interviews for DSM IV Axis I Disorders (Research Version 2/96 Final) 1996, Biometrics Research Department, NY State Psychiatric Institute, New York, NY.
14. Glahn D.C., Bearden C.E., Niendam T.A., Escamilla M.A. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004, 6:171-182.
15. Glaser R., Rice J., Sheridan J., Fertel R., Stout J., Speicher C., et al. Stress-related immune suppression: health implications. Brain Behav Immun 1987, 1:7-20.
16. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
17. Kessing L.V. Cognitive impairment in the euthymic phase of affective disorder. Psychol Med 1998, 28:1027-1038.
18. Ledgerwood L.G., Ewald P.W., Cochran G.M. Genes, germs, and schizophrenia: an evolutionary perspective. Perspect Biol Med 2003, 46:317-348.
19. Lehmann A.F. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval Program Plann 1983, 6:143-151.
20. Leverich G.S., Post R.M., Keck P.E., Altshuler L.L., Frye M.A., Kupka R.W., et al. The poor prognosis of childhood-onset bipolar disorder. J Pediatr 2007, 150:485-490.
21. Leweke F.M., Gerth C.W., Koethe D., Klosterkotter J., Ruslanova I., Krivogorsky B., et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004, 254:4-8.
22. Lokensgard J.R., Cheeran M.C., Hu S., Gekker G., Peterson P.K. Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis. J Infect Dis 2002, 186(Suppl 2):S171-S179.
23. Martinez-Aran A., Vieta E., Reinares M., Colom F., Torrent C., Sanchez-Moreno J., et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004, 161:262-270.
24. Martinez-Aran A., Vieta E., Torrent C., Sanchez-Moreno J., Goikolea J.M., Salamero M., et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007, 9:103-113.
25. McDonald C., Zanelli J., Rabe-Hesketh S., Ellison-Wright I., Sham P., Kalidindi S., et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 2004, 56:411-417.
26. Merikangas K.R., Akiskal H.S., Angst J., Greenberg P.E., Hirschfeld R.M., Petukhova M., et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007, 64:543-552.
27. Oliver J.P., Huxley P.J., Priebe S., Kaiser W. Measuring the quality of life of severely mentally ill people using the Lancashire Quality of Life Profile. Soc Psychiatry Psychiatr Epidemiol 1997, 32:76-83.
28. Paykel E.S., Weissman M., Prusoff B.A., Tonks C.M. Dimensions of social adjustment in depressed women. J Nerv Ment Dis 1971, 152:158-172.
29. Pebody R.G., Andrews N., Brown D., Gopal R., De Melker H., Francois G., et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004, 80:185-191.
30. Rajkowska G., Halaris A., Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 2001, 49:741-752.
31. Randolph C., Tierney M.C., Mohr E., Chase T.N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol 1998, 20:310-319.
32. Rosa A.R., Reinares M., Franco C., Comes M., Torrent C., Sanchez-Moreno J., et al. Clinical predictors of functional outcome of bipolar patients in remission. Bipolar Disord 2009, 11:401-409.
33. Rubinsztein J.S., Michael A., Paykel E.S., Sahakian B.J. Cognitive impairment in remission in bipolar affective disorder. Psychol Med 2000, 30:1025-1036.
34. Sanchez-Moreno J., Martinez-Aran A., Tabares-Seisdedos R., Torrent C., Vieta E., Ayuso-Mateos J.L. Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom 2009, 78:285-297.
35. Sanchez-Morla E.M., Barabash A., Martinez-Vizcaino V., Tabares-Seisdedos R., Balanza-Martinez V., Cabranes-Diaz J.A., et al. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients. Psychiatry Res 2009, 169:220-228.
36. Scott J., Stanton B., Garland A., Ferrier I.N. Cognitive vulnerability in patients with bipolar disorder. Psychol Med 2000, 30:467-472.
37. Shapira B., Zislin J., Gelfin Y., Osher Y., Gorfine M., Souery D., et al. Social adjustment and self-esteem in remitted patients with unipolar and bipolar affective disorder: a case-control study. Compr Psychiatry 1999, 40:24-30.
38. Sobczak S., Honig A., van Duinen M.A., Riedel W.J. Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disord 2002, 4:347-356.
39. Steiner I., Mador N., Reibstein I., Spivack J.G., Fraser N.W. Herpes simplex virus type 1 gene expression and reactivation of latent infection in the central nervous system. Neuropathol Appl Neurobiol 1994, 20:253-260.
40. Strandberg T.E., Pitkala K., Eerola J., Tilvis R., Tienari P.J. Interaction of herpesviridae, APOE gene, and education in cognitive impairment. Neurobiol Aging 2005, 26:1001-1004.
41. Tewes U. HAWIE-R - Hamburg Wechsler Intelligenztest für Erwachsene Revision 1991, Hogrefe, Göttingen.
42. Tham A., Engelbrektson K., Mathe A.A., Johnson L., Olsson E., Aberg-Wistedt A. Impaired neuropsychological performance in euthymic patients with recurring mood disorders. J Clin Psychiatry 1997, 58:26-29.
43. Wechsler D. Manual of the Wechsler Memory Scale-III 1997, Psychological Corporation, San Antonio.
44. Weissman M.M., Prusoff B.A., Thompson W.D., Harding P.S., Myers J.K. Social adjustment by self-report in a community sample and in psychiatric outpatients. J Nerv Ment Dis 1978, 166:317-326.
45. Wingo A.P., Harvey P.D., Baldessarini R.J. Neurocognitive impairment in bipolar disorder patients: functional implications. Bipolar Disord 2009, 11:113-125.
46. Wittchen H.U., Wunderlich U., Gruschwitz S., Zaudig M. Strukturiertes Klinisches Interview für DSM-IV 1997, Hogrefe, Göttingen.
47. Xu F., Sternberg M.R., Kottiri B.J., McQuillan G.M., Lee F.K., Nahmias A.J., et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. Jama 2006, 296:964-973.
48. Yolken R. Viruses and schizophrenia: a focus on herpes simplex virus. Herpes 2004, 11(Suppl 2):83A-88A.
49. Yolken R.H., Torrey E.F. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995, 8:131-145.